Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in WHO Functional Class I
C. Billings (Sheffield, United Kingdom), R. Lewis (Sheffield, United Kingdom), I. Armstrong (Sheffield, United Kingdom), J. Hurdman (Sheffield, United Kingdom), I. Smith (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), C. Elliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), I. Sabroe (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), R. Thompson (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom)
Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Billings (Sheffield, United Kingdom), R. Lewis (Sheffield, United Kingdom), I. Armstrong (Sheffield, United Kingdom), J. Hurdman (Sheffield, United Kingdom), I. Smith (Sheffield, United Kingdom), M. Austin (Sheffield, United Kingdom), C. Elliot (Sheffield, United Kingdom), A. Charalampopoulos (Sheffield, United Kingdom), I. Sabroe (Sheffield, United Kingdom), A. Lawrie (Sheffield, United Kingdom), R. Thompson (Sheffield, United Kingdom), R. Condliffe (Sheffield, United Kingdom), D. Kiely (Sheffield, United Kingdom). Incremental shuttle walking test distance is reduced in patients with pulmonary hypertension in WHO Functional Class I. 3323
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Incremental shuttle walking test distance predicts poor prognosis in pulmonary hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004
Differences in foot loading during Incremental shuttle walked test between patients with severe chronic obstructive pulmonary disease and healthy controls Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016
The incremental shuttle walk test in pulmonary hypertension Source: International Congress 2019 – Exercise tolerance and its determinants across pathologies Year: 2019
Effects of sildenafil on incremental shuttle walking test and haemodynamics in patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 370s Year: 2002
The incremental shuttle walking test safely assesses exercise capacity in pulmonary hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004
Incremental shuttle walking test evaluates the maximal exercise capacity of patients with lymphangioleiomyomatosis Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Reduced incremental shuttle walking test distance is associated with a worse survival in pulmonary arterial hypertension associated with systemic sclerosis Source: Eur Respir J 2007; 30: Suppl. 51, 343s Year: 2007
Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011
Relationship between sit-to-stand test and six-minute walk test in patients with pulmonary arterial hypertension Source: International Congress 2015 – The challenge of choosing the best physical and functional assessment methods Year: 2015
Percent-predicted incremental shuttle walking test distance stratifies risk in pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020
Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 16s Year: 2005
Prognostic variables for the incremental shuttle walking test in patients with COPD Source: Annual Congress 2011 - Measuring physical activity and exercise performance in chronic lung disease: implications for rehabilitation Year: 2011
Repeatability of incremental shuttle and 6 minute walk test in pulmonary hypertension Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009
What is the minimum clinically important difference in the incremental shuttle walking test (ISWT) observed in pulmonary rehabilitation? Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002
Comparative assessment of the incremental shuttle walk and incremental cycle ergometry tests in patients with idiopathic pulmonary fibrosis. Source: Virtual Congress 2020 – Advances in lung function practice Year: 2020
Reduced six-minute walking distance is associated with endothelial dysfunction in COPD patients Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation Year: 2011
Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009
Determinants of cardio-pulmonary exercise test (CPET) and shuttle walking test (SWT) in COPD patients are different Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases Year: 2015
Evaluating impairment in exercise capacity in COPD patients with the six-minute walk distance test: a comparative study Source: Eur Respir J 2006; 28: Suppl. 50, 767s Year: 2006
Comparison of the six minute walking test, the shuttle test and the cardiopulmonary exercise test in the evaluation of patients with established PAH Source: Annual Congress 2005 - Exercise testing in pulmonary arterial hypertension Year: 2005